Key result
Antiplatelet therapy for stroke prevention in atrial fibrillation is the subject of this Cochrane Review protocol, which currently reports no clinical findings.
Why the study?
Does antiplatelet therapy prevent stroke in people with atrial fibrillation?
Does antiplatelet therapy prevent stroke in people with atrial fibrillation?
This protocol outlines a planned Cochrane Review to evaluate the beneficial and harmful effects of antiplatelet therapy for stroke prevention in atrial fibrillation.
Answers are grounded in this paper and cite their sources.
No practice change indicated by this protocol alone; forthcoming Cochrane review will synthesize antiplatelet effects for stroke prevention in atrial fibrillation.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of antiplatelet therapy for prevention of stroke in people with atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Karlsson et al. (2016) studied this question. Antiplatelet therapy for stroke prevention in atrial fibrillation is the subject of this Cochrane Review protocol, which currently reports no clinical findings.
Synapse has enriched 10 related papers. Consider them for comparative context: